SIGALA, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 12.099
AS - Asia 5.851
EU - Europa 5.036
SA - Sud America 956
Continente sconosciuto - Info sul continente non disponibili 345
AF - Africa 124
OC - Oceania 18
Totale 24.429
Nazione #
US - Stati Uniti d'America 11.872
SG - Singapore 2.000
CN - Cina 1.926
IT - Italia 956
UA - Ucraina 897
BR - Brasile 767
HK - Hong Kong 650
DE - Germania 616
PL - Polonia 584
FR - Francia 479
FI - Finlandia 462
VN - Vietnam 408
GB - Regno Unito 282
RU - Federazione Russa 213
IN - India 188
TR - Turchia 186
BD - Bangladesh 176
IE - Irlanda 161
CA - Canada 128
SE - Svezia 96
NL - Olanda 61
JP - Giappone 60
AR - Argentina 58
BE - Belgio 57
ID - Indonesia 50
IQ - Iraq 43
ZA - Sudafrica 39
MX - Messico 38
EC - Ecuador 37
CZ - Repubblica Ceca 34
ES - Italia 30
PK - Pakistan 28
VE - Venezuela 24
CL - Cile 19
CO - Colombia 19
AT - Austria 18
NG - Nigeria 16
AU - Australia 15
MA - Marocco 14
SA - Arabia Saudita 14
UZ - Uzbekistan 13
CR - Costa Rica 12
JM - Giamaica 12
LT - Lituania 12
CH - Svizzera 11
EG - Egitto 11
IR - Iran 11
KE - Kenya 11
PY - Paraguay 11
DK - Danimarca 10
EE - Estonia 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
PH - Filippine 8
BG - Bulgaria 7
DZ - Algeria 7
HN - Honduras 7
PE - Perù 7
AZ - Azerbaigian 6
JO - Giordania 6
KR - Corea 6
MU - Mauritius 6
NP - Nepal 6
PS - Palestinian Territory 6
UY - Uruguay 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
GR - Grecia 5
IL - Israele 5
LB - Libano 5
MY - Malesia 5
OM - Oman 5
PT - Portogallo 5
TW - Taiwan 5
AL - Albania 4
BH - Bahrain 4
EU - Europa 4
GT - Guatemala 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NI - Nicaragua 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BS - Bahamas 3
GD - Grenada 3
GE - Georgia 3
GY - Guiana 3
LV - Lettonia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
ET - Etiopia 2
MD - Moldavia 2
Totale 24.066
Città #
Fairfield 1.045
Ashburn 1.030
Singapore 1.009
Woodbridge 835
Jacksonville 653
Hong Kong 644
San Jose 589
Warsaw 578
Houston 532
Seattle 427
Cambridge 421
Dallas 400
Ann Arbor 377
Beijing 366
Wilmington 356
Chandler 331
Los Angeles 292
The Dalles 292
Princeton 289
Helsinki 276
Chicago 263
New York 258
Council Bluffs 238
Nanjing 227
Brescia 221
Dearborn 169
Dublin 161
Lauterbourg 156
Istanbul 149
Columbus 144
Ho Chi Minh City 124
Des Moines 108
Nanchang 108
Munich 106
Buffalo 104
Salt Lake City 101
Santa Clara 90
Moscow 86
Milan 83
Hanoi 76
Shenyang 70
Secaucus 68
Shanghai 66
São Paulo 66
Turku 64
Changsha 60
San Francisco 59
Jinan 57
Brussels 56
Redondo Beach 55
San Diego 55
Orem 54
Tianjin 54
Elk Grove Village 53
Tampa 53
Dong Ket 48
Hebei 48
Toronto 47
Pune 45
Lancaster 42
West Jordan 42
London 41
Rome 41
Tokyo 38
Boardman 37
Phoenix 37
Brooklyn 32
Kunming 32
Jakarta 31
Jiaxing 31
Sterling 31
Ningbo 28
Montreal 27
Rio de Janeiro 25
Chennai 24
Verona 24
Brno 23
Zhengzhou 23
Boston 22
Hangzhou 22
Johannesburg 22
Stockholm 22
Atlanta 21
Frankfurt am Main 21
Guangzhou 21
Miami 21
Taizhou 21
Amsterdam 20
Haiphong 20
Nuremberg 20
Denver 19
Dalmine 18
Haikou 17
Naples 17
Poplar 17
Kyiv 16
Manchester 16
Turin 16
Abuja 15
Da Nang 15
Totale 15.820
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 794
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 388
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 385
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 322
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 300
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 284
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 261
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 253
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 249
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 230
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 227
Immunotherapy failure in adrenocortical cancer: where next? 226
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 221
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 217
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 216
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 215
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 213
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 212
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 209
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 208
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 207
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 205
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 202
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 199
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 198
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 195
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 191
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 191
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 191
A new pharmacological approach to the facilitation of acetylcholine transmission. 190
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 190
Palbociclib inhibits proliferation of human adrenocortical tumor cells 190
Should we be cautious on the use of commercially available antibodies to dopamine receptors? 189
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 188
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 188
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 188
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 183
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 179
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 176
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 176
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 170
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 169
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 169
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 168
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 168
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 165
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 164
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? 161
INVOLVEMENT OF TARGET GENE POLYMORPHISMS IN 5-FLUOROURACIL TOXICITY: A CASE REPORT 161
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 159
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 158
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 157
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 152
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. 151
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines 151
Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs 149
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 148
Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. 143
Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer 141
Different neurotransmitter systems are involved in the development of esophageal achalasia 140
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 139
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 139
Adrenocortical carcinoma 138
Sex-related variations in serum nerve growth factor concentration in humans. 137
Nerve growth factor signaling in prostate health and disease. 137
Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. 137
Erratum to "Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa" [Pharmacol. Res. 64 (2011) 420-425] 136
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 136
Dopamine receptors are present in rat and human esophagus 135
Clinical Outcome After Extended Endovascular Recanalization in Buerger's Disease in 20 Consecutive Cases. 134
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 133
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 133
Detection of muscarinic receptor subtypes in human urinary bladder mucosa: Age and gender-dependent modifications 133
I RECETTORI ADRENERGICI ALFA-1 NELL'APPARATO URINARIO UMANO: ESPRESSIONE DISTRIBUZIONE E LORO IMPLICAZIONI CLINICHE 133
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 131
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 129
Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment 129
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 128
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 128
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 128
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure 126
Caffeine inhibits Direct and Indirect Angiogenesis in zebrafish embryos 125
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism 125
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice. 125
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 125
Evidence for the presence of D1 and D2 dopamine receptors in rat oesophagus 124
ALPHA 1 ADRENERGIC RECEPTOR SUBTYPES IN MALE AND FEMALE HUMAN URINARY BLADDER: SEX AND REGIONAL COMPARISON 123
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 122
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 121
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 121
Ruolo dei recettori della dopamina nella regolazione motoria dello sfintere esofageo inferiore del ratto 121
Structural comparison Analysis of Erythropoietin and its biosimilars by a proteomic approach 121
Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment 121
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines 120
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 117
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 117
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 117
D-1 and D-2 dopamine receptors in rat lower esophageal sphincter: a functional study 116
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 115
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 115
Totale 17.680
Categoria #
all - tutte 110.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.227


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022950 0 0 38 68 15 58 63 76 61 152 111 308
2022/20231.060 188 62 47 79 81 258 6 87 131 14 39 68
2023/20241.391 70 39 125 99 81 250 49 66 282 70 34 226
2024/20254.142 55 46 32 522 341 246 294 109 491 248 942 816
2025/20266.949 550 864 757 917 608 391 978 312 436 668 292 176
2026/2027885 332 291 262 0 0 0 0 0 0 0 0 0
Totale 24.429